Breathe Well Live Well
|
Study compares LRTAs with placebo for the treatment of asthma
Pharmacy Today, American Pharmacists Association, pharmacist.com Researchers conducted a systematic review and meta-analysis to compare leukotriene-receptor antagonists (LTRAs) with placebo in patients with mild asthma. The review, funded by NIH, included 50 randomized trials conducted through June 2015. |
View full post on asthma – Google News
|
5 Lesser-Known Asthma Triggers
Pharmacy Times Patient education about asthma triggers is especially important, considering that more than 18.7 million adults have asthma, and the condition costs the United States $56 billion a year, according to the US Centers for Disease Control and Prevention (CDC). |
View full post on asthma – Google News
JAMA: The Journal of the American Medical Association |
Study compares combination treatments for African-American adults with asthma
Pharmacy Today, American Pharmacists Association, pharmacist.com The primary outcome was time to asthma exacerbation that required oral or parenteral corticosteroids. The results showed no difference between LABA plus ICS compared with tiotropium plus ICS in the primary outcome. There were also no significant … LABAs, tiotropium perform similarly in black patients with asthma Anticholinergic vs Long-Acting ?-Agonist in Combination With Inhaled … Study Compares Combination Treatments for Black Adults with Asthma |
View full post on asthma – Google News
Pharmacy Times |
Asthma: Helping Children and Caregivers Breathe Easier
Pharmacy Times Asthma, a chronic inflammatory disease that occurs in the airways due to a complex interaction of factors,1 is characterized by symptoms that cause reversible airway narrowing and increased airway responsiveness to a variety of stimuli. The reversible … |
View full post on asthma – Google News
|
Pediatric Asthma Research Gets NIH Grant Funding
Pharmacy Times The National Institutes of Health (NIH) has awarded universities about $28 million in grants to study pediatric asthma triggers. Thanks to the grants, researchers will be able to develop wearable and non-wearable sensors that track pediatric … |
View full post on asthma – Google News
|
Spiriva Respimat Now Approved for Asthma
Pharmacy Times The FDA has added an asthma indication to Boehringer Ingelheim's tiotropium bromide inhalation spray (Spiriva Respimat). This long-acting muscarinic antagonist (LAMA) was originally approved in September 2014 for the maintenance treatment of chronic … FDA approves Spiriva Respimat for asthma in adults, adolescents |
View full post on asthma – Google News
|
Why Corticosteroids Poorly Control Severe Asthma
Pharmacy Times The approximate 1 in 10 asthma patients who have severe disease do not respond to mainstay corticosteroid treatment, even in high doses. That could be because the immune response that occurs in the airways of severe asthma patients markedly differs … |
View full post on asthma – Google News
University Herald |
Pharmacists Shouldn't Bother Recommending Soy Supplements for Asthma
Pharmacy Times “Pharmacists can say that there is no evidence that taking soy isoflavone supplements will benefit patients with asthma, but there is also no evidence that they will cause any harm,” he said. “If individuals with asthma want to use these supplements … Soy May Be Ineffective In Asthma Care Soy supplements don't cure asthma, says study Soy supplements do not appear to improve asthma |
View full post on asthma – Google News
The Pharmaceutical Journal |
Pharmacists Can Correct Asthma Controller Medication Underuse
Pharmacy Times A study published May 4, 2015 in Pediatrics analyzed data from 35,467 asthma medication prescriptions filled between January 31, 2010, and January 30, 2012, for children aged 2 to 17 years in Hamilton County, Ohio. Classifying the asthma medications as … Pharmacies could play a role in reducing asthma-related deaths |
View full post on asthma – Google News
|
Patients Reluctant to Address Work-Related Asthma
Pharmacy Times (registration) Researchers reviewed data from the 2006 to 2010 Behavioral Risk Factor Surveillance System Asthma Call-Back Survey, which included more than 50,000 employed adults 18 years and older with asthma. They determined that 14.7% of those patients had … |
View full post on asthma – Google News